The point-of-care diagnostics market is expected to
reach USD 36.96 Billion by 2021 from USD 23.16 Billion in 2016, at a
CAGR of 9.8% during the forecast period. Base year considered for the report is 2015 and forecast period is 2016–2021.
Objectives of the Study
- To define, describe, and forecast the global point-of-care diagnostics market on the basis of product, prescription mode, end user, and region
- To provide detailed information regarding major factors influencing growth of the Point-of-Care Diagnostics market (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To provide a five-year forecast for various segments of the point-of-care diagnostics market, in terms of revenue, with respect to regions, namely, North America (U.S. and Canada), Europe (Germany, France, the U.K., and Rest of Europe), Asia-Pacific (India, China, Japan, and Rest of Asia-Pacific), and the Rest of the World
- To strategically profile the key players and comprehensively analyze their market shares and core competencies
- To track and analyze competitive developments such as new product launches; agreements, partnerships, and joint ventures; and mergers and acquisitions in the global point-of-care diagnostics market
This research study involved the extensive usage of
secondary sources, directories, and databases (such as Hoovers,
Bloomberg Business, Factiva, and Avention) to identify and collect
information useful for this technology-based, market-oriented, and
commercial study of the global point-of-care diagnostics market.
In-depth interviews were conducted with various primary respondents that
mainly included key industry participants, subject-matter experts
(SMEs), C & D-level executives of key market players, and
independent industry consultants, among others; to obtain and verify
critical qualitative and quantitative information as well as to assess
future market prospects of the global point-of-care diagnostics
industry.
The secondary sources referred to for this research
study include corporate filings (such as annual reports, SEC filings,
investor presentations, and financial statements); research journals;
press releases; as well as articles published by various trade,
business, and professional associations. Secondary sources were used to
identify and collect useful information for this extensive, technical,
and market-oriented study of the global point-of-care diagnostics
market.
As of 2015, Abbott Laboratories, Inc. (U.S.),Roche
Diagnostics Limited (Switzerland), Siemens AG (Germany), Beckman
Coulter, Inc. (U.S.),Becton, Dickinson and Company (U.S.), Johnson &
Johnson (U.S.), Alere Inc. (U.S.), Instrumentation Laboratory (U.S.),
PTS Diagnostics (U.S.), and Nova Biomedical (U.S.) are some of the key
players in the point-of-care diagnostics market. These players are
striving to expand their presence in the emerging countries of
Asia-Pacific region through partnerships, agreements, and
collaborations.
Global Point-of-care Diagnostics Market, by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
- Rest of the World
Comments
Post a Comment